(Q39749031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

review article

1 reference

title

Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

main subject

arterial hypertension

0 references

author

Pietro Ameri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Edoardo Bertero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Giovanni Meliota

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

6

Claudio Brunelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Martino Cheli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Marco Canepa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Manrico Balbi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

1 reference

1 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

published in

Heart Failure Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

539-547

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10741-016-9566-3

2 April 2020

exact match

0 references

cites work

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Importance of angiotensin-converting enzyme in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

The autonomic nervous system and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Effects of oxygen breathing on pulmonary vascular input impedance in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Ambulatory pulmonary arterial pressure in primary pulmonary hypertension: variability, relation to systemic arterial pressure, and plasma catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Derangement of autonomic nerve control in rat with right ventricular failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Effects of a pure alpha/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Quantitative assessment of right ventricular glucose metabolism in idiopathic pulmonary arterial hypertension patients: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Captopril attenuates matrix metalloproteinase-2 and -9 in monocrotaline-induced right ventricular hypertrophy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Treatment of group I pulmonary arterial hypertension with carvedilol is safe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Captopril in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-016-9566-3

Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise

21 January 2018

1 reference

12 December 2020

Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension

1 reference

12 December 2020

Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension

1 reference

12 December 2020

Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.

1 reference

12 December 2020

Beta blocker for patients with pulmonary arterial hypertension: A single center experience

1 reference

12 December 2020

Correlation between severity of pulmonary arterial hypertension and 123I-metaiodobenzylguanidine left ventricular imaging

1 reference

12 December 2020

Chronic propranolol treatment blunts right ventricular hypertrophy in rats at high altitude

1 reference

12 December 2020

Increased sympathetic nerve activity in pulmonary artery hypertension

1 reference

12 December 2020

Bisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension

1 reference

12 December 2020

Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure

1 reference

12 December 2020

Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure

1 reference

12 December 2020

Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart

1 reference

12 December 2020

Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension

1 reference

12 December 2020

β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis

1 reference

12 December 2020

Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia

1 reference

12 December 2020

Nebivolol for Improving Endothelial Dysfunction, Pulmonary Vascular Remodeling, and Right Heart Function in Pulmonary Hypertension

1 reference

12 December 2020

10.1007/S10741-016-9566-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27206576%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference